OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong, Dongjie Li, Hongbo Meng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3650-3666
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

GPX4 in cell death, autophagy, and disease
Yangchun Xie, Rui Kang, Daniel J. Klionsky, et al.
Autophagy (2023) Vol. 19, Iss. 10, pp. 2621-2638
Open Access | Times Cited: 230

Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis
Jie Tong, Xiu-Ting Lan, Zhen Zhang, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 1014-1028
Closed Access | Times Cited: 102

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56

Updated mechanisms of MASLD pathogenesis
Yuxuan Li, Peipei Yang, Jialu Ye, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 45

Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis
Teng Zhang, Meng‐Yan Wang, Guodong Wang, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176341-176341
Closed Access | Times Cited: 23

Iron, Oxidative Stress, and Metabolic Dysfunction—Associated Steatotic Liver Disease
Sophie Gensluckner, Bernhard Wernly, Christian Datz, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 208-208
Open Access | Times Cited: 23

Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence
Di-Yang Sun, Wenbin Wu, Jianjin Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22

Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis
Hong-liang Qiu, Sihui Huang, Yuting Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2581-2597
Open Access | Times Cited: 20

Targeting ferroptosis: Paving new roads for drug design and discovery
Yilin Gu, Yizhe Li, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115015-115015
Closed Access | Times Cited: 53

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway
Tianyu Jiang, Yao Xiao, Jinfeng Zhou, et al.
Redox Biology (2023) Vol. 68, pp. 102963-102963
Open Access | Times Cited: 36

Towards understandings of serine/arginine-rich splicing factors
D. Li, Wenying Yu, Maode Lai
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3181-3207
Open Access | Times Cited: 33

MAFLD as part of systemic metabolic dysregulation
Jing Zhao, Lu Liu, Yingying Cao, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 834-847
Closed Access | Times Cited: 15

Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease
Yutong Sui, Xue Geng, Ziwei Wang, et al.
Metabolism (2024) Vol. 157, pp. 155953-155953
Closed Access | Times Cited: 13

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment
Jiang‐Tao Fu, Ping Zhang, Zhiguo Sun, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2228-2246
Open Access | Times Cited: 11

Microbial metabolite deoxycholic acid-mediated ferroptosis exacerbates high-fat diet-induced colonic inflammation
Chen Wang, Qiao Chu, Wenxiao Dong, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101944-101944
Open Access | Times Cited: 11

Heme oxygenase 1-mediated ferroptosis in Kupffer cells initiates liver injury during heat stroke
Ru Li, Riqing Wei, Chenxin Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3983-4000
Open Access | Times Cited: 11

Gasdermin‐E‐Dependent Non‐Canonical Pyroptosis Promotes Drug‐Induced Liver Failure by Promoting CPS1 deISGylation and Degradation
Shen‐Xi Ouyang, Jiahui Zhu, Qi Cao, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 9

Stable Transmission of DNA Methylation Epimutations from Germlines to the Liver and Their Association with Fatty Liver Disease in Medaka
Sourav Chakraborty, Santosh Anand, Xuegeng Wang, et al.
Research Square (Research Square) (2025)
Closed Access | Times Cited: 1

Ferroptotic stress facilitates smooth muscle cell dedifferentiation in arterial remodelling by disrupting mitochondrial homeostasis
Qing‐Xin Ji, Fei‐Yan Zeng, Jian Zhou, et al.
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 457-474
Closed Access | Times Cited: 34

Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation
Si-Jia Sun, Xiao‐Dong Jiao, Zhigang Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts
Fa‐Li Zhang, Yu Xiao, Zhongzhou Huang, et al.
Free Radical Biology and Medicine (2024) Vol. 221, pp. 23-30
Closed Access | Times Cited: 6

Sodium Butyrate Alleviates Free Fatty Acid-Induced Steatosis in Primary Chicken Hepatocytes via Regulating the ROS/GPX4/Ferroptosis Pathway
Xinyi Cheng, Yang Hu, Xiaoqing Yu, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 140-140
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top